NFL legend Tom Brady has reportedly taken a groundbreaking step off the field — cloning his late dog through biotechnology firm Colossal Bioscience. According to reports obtained by PEOPLE, the former quarterback used a blood sample from his previous dog, Lua, who passed away in 2023. The cloned pup, named Junie, is now part of Brady’s family. The revelation has reignited debates about celebrity pet cloning and ethical questions surrounding such practices.
The seven-time Super Bowl champion confirmed that he partnered with Colossal Bioscience, a Dallas-based biotech company known for its genetic innovation. Brady shared that before Lua’s passing, he worked with Colossal’s team to use a non-invasive cloning process involving a small blood draw.
Brady explained that the process allowed his family to preserve Lua’s DNA, resulting in Junie — a pitbull mix genetically identical to his former pet. The star athlete, who has invested in Colossal, praised the company’s pioneering technology and its work on reviving endangered species.
“I love my animals. They mean the world to me and my family,” Brady said in a statement to PEOPLE. “A few years ago, I worked with Colossal and leveraged their non-invasive cloning technology through a simple blood draw of our family’s elderly dog before she passed.”
Quotes & Reactions
Colossal Bioscience also confirmed the collaboration, emphasizing that its technology is not limited to celebrity clients but could soon support broader conservation projects.
“Tom’s case reflects a personal application of our cloning technology,” a company spokesperson said. “Our goal remains to advance genetic preservation for both families and endangered species.”
Meanwhile, animal welfare groups have expressed mixed opinions, with some raising concerns about the ethics of cloning pets for emotional reasons rather than conservation purposes.
What It Means for Brady and Beyond
For Tom Brady, this revelation underscores his deep emotional connection to Lua and his ongoing interest in biotechnology ventures. His investment in Colossal aligns with his post-retirement focus on science, health, and longevity — echoing his earlier ventures like TB12 Sports.
While the cloning has no direct bearing on Brady’s football legacy, it adds a new dimension to his public persona as a tech-forward athlete embracing future-facing innovations.
What’s Next
Colossal Bioscience continues to expand its genetic research programs, including projects aimed at bringing back extinct species such as the woolly mammoth. As for Brady, he remains active in business and media, with sources suggesting he may collaborate with Colossal on an educational campaign about ethical cloning and pet health.
Sources
PEOPLE – “Tom Brady Clones His Dog Using Colossal Bioscience Technology”
ESPN – Background coverage on Brady’s post-retirement ventures
247Sports – Player biography and updates
On3 – NFL star business involvement reports
